A media report said that the US Center for Medicare and Medicaid released a preliminary list of 101 generic drugs.

The Nifty Pharma index has so far this year gained 54.42 percent while the benchmark Nifty advanced 26.94 percent in the same ...

Stay up-to-date with the Cipla Stock Liveblog, your trusted source for real-time updates and thorough analysis of a prominent ...

The Indian market is expected to consolidate on Thursday, influenced by mixed global cues. The Nifty futures experienced a ...

Cipla (EU) Ltd. will acquire the entire 6.9% equity interest of Jiangsu Xidi Pharmaceuticals Co. in the subsidiary for 35 ...

Discover the Cipla Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a ...

UBS highlights growth opportunities for Sun Pharma and Cipla while raising alarms about profitability pressures in the Indian ...

The Indian benchmark indices were a mixed bag on the weekly expiry day of October 10. The Sensex closed in the positive ...

CIPLA daily chart is indicating a continued push higher through 1758-60 zone going forward. This would terminate Minor Wave 5 Grey of Intermediate Wave (5) Orange and complete the uptrend at larger ...

One such company to wither the current storm that has hit some pharma companies is Cipla. The Mumbai-based pharma company saw its shares rise by over 2 per cent in the day's trade. Recently ...

The Sensex gained 144.31 points, or 0.18, to settle at 81467.1, while the Nifty gained 16.5 points, or 0.07, to close at ...

Cipla (EU) Limited, UK a wholly owned subsidiary of Cipla Limited (BSE:500087; NSE: Cipla EQ], hereinafter referred to as Cipla has announced a strategic collaboration with Kemwell Biopharma ...